Report: Physician-Owned Entities Could Reduce Device Implant Prices
Allowing physician-owned entities to purchase surgical implants lowers costs and improves pricing transparency if done correctly, a legal expert maintains. But federal guidance is needed to ensure such businesses comply with Medicare pricing and reimbursement policy.
Writing in the May 23 issue of Food & Drug Policy Forum, Joseph Truhe, senior vice president and general counsel at PDP Holdings in Nashville, Tenn., says guidance could help explain how physician-owned entities might be structured and what features might lead to fraud. At the same time, Congress and the Centers for Medicare & Medicaid Services should work on reforms to make surgical implant pricing more transparent, such as barring confidentiality provisions that prevent negotiation.
The U.S. healthcare system once rewarded (and paid for) performing individual procedures; now it is evolving toward a system that will penalize (over)utilization and instead reward efficiency, delivering quality health outcomes and producing measurable cost savings.
Whether the Supreme Court strikes down part or all of the Affordable Care Act, or decides to leave the law unchanged, securing profitable coverage, unique coding and appropriate, value-based payment for medical devices and diagnostics will continue.
In just 90 minutes, you’ll dig deep into the finer points of device reimbursement strategies and how to prepare for the changes ahead. Don’t wait and miss out on this amazing opportunity, register for Wednesday’s webinar today!
Come for this valuable opportunity to hear FDA officials discuss regulatory plans and objectives — and ask questions you need answered; learn from device industry experts, consultants and other experts with actionable tips and strategies you can take straight back to the office; and network with other professionals who understand your challenges; share war stories and insights over a drink. Register Today.Read More
The FDA's new enforcement plan makes one thing clear: Developing a successful CAPA program has never been more important. But creating an FDA-proof CAPA isn’t easy. If only you could pick the brain of someone who is coping successfully with CAPA — the best and the brightest, an industry leader who has devised programs, procedures and solutions that have put companies out in front with the FDA. Well, you can. Register today.Read More
The FDA’s cadre of freshly trained inspectors — many of whom come directly from industry — and increased focus on specialized inspections are making it harder than ever to predict the outcome of your next FDA inspection. Unless, of course, you have Surviving an FDA Inspection at your fingertips. If you could spend less than $400 to get your drug manufacturing facility fully prepared to face a tough inspection by the FDA, would you even hesitate? ... Of course not!